You are here: Industry Insights > CEO

News List

Sanofi Names New CEO contractpharma
June 10, 2019
Paul Hudson to succeed Olivier Brandicourt as of September 1st.
Avadel Pharma Appoints CEO contractpharma
June 04, 2019
Mr. Divis has served in the role on an interim basis since January.
Advice for medtech startups: Don’t do your homework, CEOs say fiercebiotech
May 10, 2019
All startups face challenges. But sometimes, it may serve companies better in the long run if their founders don’t know just what those challenges will be.
Aprecia Appoints CEO contractpharma
April 19, 2019
Chris Gilmore has been named chief executive officer, Aprecia. Mr. Gilmore will lead the company on expanding access to 3D-printed pharmaceutical products globally.
Pall, ARTeSYN Biosolutions Expand Single-Use Technology Alliance contractpharma
April 03, 2019
Co-development partnership aims to deliver complete solutions from clinical to commercial-scale for single-use automated bioprocessing systems
Dr. Gustavo Mahler Resigns as Chief Executive Officer of AGC Biologics, Patricio Massera to Succeed as CEO Effective May 1st, 2019 en-cphi.cn
April 03, 2019
AGC Biologics today announces a change in executive leadership. Dr. Gustavo Mahler has decided to leave his position as CEO effective April 30th, 2019 after a 10 year tenure with CMC Biologics and AGC Biologics.
Glenmark appoints Alessandro Riva as CEO of its new innovation company in US expressbpd
March 07, 2019
The appointment is effective April 2, 2019
AZ’s CEO dismisses “fake news” about his imminent departure pharmaphorum
February 15, 2019
AstraZeneca’s CEO Pascal Soriot has dismissed continued rumours about his departure as “fake news” as the company announced full year results showing sales growth for the first time in a decade.
Seres elevates CFO Eric Shaff to CEO post as it advances immunology therapies fiercebiotech
January 17, 2019
Seres Therapeutics is promoting its chief operating and financial officer, Eric Shaff, to succeed Roger Pomerantz as its new president and CEO......
UroGen appoints former Novartis cancer chief Barrett as CEO pharmaphorum
January 09, 2019
Novartis’ former oncology CEO Liz Barrett has left to join a little known biotech, UroGen, to help bring its potential urothelial cancer drug to market.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page